Perspective · 30 Apr 2025
Review articlePublished 2012
Molecularly Targeted Therapy: Past, Present and Future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a heterogeneous disease with diverse underlying molecular causes and equally diverse clinical profiles. It has long been a goal to develop cancer therapies that would be distinct and appropriate for each patient. The recent concept of “oncogene addiction” has been very helpful in guiding this path “from the bench to the bed”. The most significant advance in the treatment of cancer in the past few decades has been the introduction of molecularly targeted therapies, such as imatinib for chronic myelogenous leukemia and gefitinib for lung cancer. In addition, many new promising agents have been developed in the laboratory and are now entering clinical testing. Thus, our current challenge is to better understand how to utilize these agents in clinical practice and to better understand the mechanisms of drug resistance that may be encountered. Advances in these areas would allow for more targeted and effective treatment options for cancer patients. This review describes the development of molecularly targeted therapies from the past achievements to current efforts, the insights learned by this effort, the problems encountered in the clinic, and the potential for novel development of next-generation kinase inhibitors.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Oct 2015
TP53 (Pro>Arg) and (Ser>Thr) hotspot mutations/polymorphisms are associated with oral squamous cell carcinoma: Novel molecular targets for future therapies
Review article · 2013
Acute myeloid leukaemia - therapy - past, present and future
Perspective · 29 May 2025
Transforming cancer therapy: The rise of molecular targeted therapy in precision oncology
Perspective · 29 Apr 2025
Targeted Molecular Therapy for Gynecologic Cancers: Advances and Clinical Applications
More from this journal
The newest in Chemotherapy: Open Access.
Perspective · 3 Nov 2025
Vulvar and Vaginal Cancers Clinical Characteristics Treatment Options and Prognosis
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yoh Dobashi”
- BylineArticles whose byline prints “Akiteru Goto”
- BylineArticles whose byline prints “Maiko Kimura”
- BylineArticles whose byline prints “Tomoyuki Nakano”

